Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
4
NMPA:4
Drug Approvals
Fluvoxamine Maleate Tablets
- Product Name
- 马来酸氟伏沙明片
- Approval Number
- 国药准字H20249819
- Approval Date
- Dec 25, 2024
NMPA
Tandospirone Citrate Tablets
- Product Name
- 枸橼酸坦度螺酮片
- Approval Number
- 国药准字H20249132
- Approval Date
- Oct 22, 2024
NMPA
Lanthanum Carbonate Chewable Tablets
- Product Name
- 碳酸镧咀嚼片
- Approval Number
- 国药准字H20233126
- Approval Date
- Feb 7, 2023
NMPA
Potassium Sodium Hydrogen Citrate Granules
- Product Name
- 枸橼酸氢钾钠颗粒
- Approval Number
- 国药准字H20213268
- Approval Date
- Apr 13, 2021
NMPA
Clinical Trials
No trials found
News
No news found